Predictors Affecting Long-term Use of Solifenacin or Mirabegron in Women With Overactive Bladder Syndrome
NCT05040984
·
clinicaltrials.gov ↗
UNKNOWN
Status
500
Enrollment
OTHER
Sponsor class
Conditions
Overactive Bladder Syndrome
Interventions
DRUG:
Solifenacin Oral Tablet
DRUG:
Mirabegron 25mg
Sponsor
Far Eastern Memorial Hospital